NHS Dudley Health Economy Medicines Formulary
Home > 10 Musculoskeletal and joint diseases > 10.1 Drugs used in rheumatic diseases and gout > 10.1.3 Drugs that suppress the rheumatic disease process > Apremilast for treating active psoriatic arthritis - NICE TAG TA372

Apremilast for treating active psoriatic arthritis - NICE TAG TA372

1.1 Apremilast alone or in combination with disease‑modifying antirheumatic drug (DMARD) therapy is not recommended within its marketing authorisation for treating adults with active psoriatic arthritis that has not responded to prior DMARD therapy, or such therapy is not tolerated.

1.2 People whose treatment with apremilast was started within the NHS before this guidance was published should be able to continue treatment until they and their NHS clinician consider it appropriate to stop.

https://www.nice.org.uk/guidance/ta372

 

Site by Devopa
© Copyright 2019 NHS. All rights reserved.